Anixa Biosciences Inc (ANIX)
Pharmaceutical Preparations
Latest Price
$2.76
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.42
P/B Ratio
6.52
Institutional Ownership
15.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.33M | $3.0M | 3.92% | +14.9K | 2026-06-30 |
| UBS Group AG | 585.4K | $1.0M | 1.73% | +33.8K | 2026-06-30 |
| Laird Norton Wetherby Trust Company, LLC | 578.7K | $1.0M | 1.71% | +12.4K | 2026-06-30 |
| D.A. DAVIDSON & CO. | 539.3K | $1.0M | 1.59% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 359.2K | $1.0M | 1.06% | -5.5K | 2026-06-30 |
| MARSHALL WACE, LLP | 328.3K | -- | 0.97% | +155.2K | 2026-06-30 |
| BlackRock, Inc. | 199.8K | -- | 0.59% | +29.7K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 192.4K | -- | 0.57% | +1.3K | 2026-06-30 |
| STATE STREET CORP | 159.0K | -- | 0.47% | -- | 2026-06-30 |
| GSA CAPITAL PARTNERS LLP | 117.5K | -- | 0.35% | +18.6K | 2026-06-30 |